https://www.selleckchem.com/pr....oducts/folinic-acid.
Results showed that MMP2 (-735CT) presented a statistically significant association with the risk of RSA under allelic (T vs C OR=1.50, 95% CI=1.14-1.98, P=0.004, I =31%), heterozygote (CT vs CC OR=1.74, 95% CI=1.22-2.50, P=0.003, I =41%) and dominant (TT+CT vs CC OR=1.74, 95% CI=1.23-2.45, P=0.002, I =40%) genetic models. MMP9 (-1562CT) in allelic (T vs C OR=1.34, 95% CI=1.08-1.65, P=0.007, I =0%), heterozygote (CT vs CC OR=1.38, 95% CI=1.06-1.79, P=0.02, I =0%) and dominant (TT+CT vs CC OR=1.41, 95% CI=1.10-1.82, P=0.008,
Like
Comment
Share
